1. Home
  2. MLSS vs ELUT Comparison

MLSS vs ELUT Comparison

Compare MLSS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.25

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.00

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
ELUT
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
23.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MLSS
ELUT
Price
$0.25
$1.00
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$1.00
$7.00
AVG Volume (30 Days)
297.3K
373.8K
Earning Date
11-13-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,929,517.00
$21,746,000.00
Revenue This Year
$8.95
N/A
Revenue Next Year
$7.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.59
24.08
52 Week Low
$0.22
$0.50
52 Week High
$1.32
$3.46

Technical Indicators

Market Signals
Indicator
MLSS
ELUT
Relative Strength Index (RSI) 35.46 63.12
Support Level $0.26 $0.89
Resistance Level $0.30 $1.07
Average True Range (ATR) 0.03 0.11
MACD -0.00 0.00
Stochastic Oscillator 35.80 61.75

Price Performance

Historical Comparison
MLSS
ELUT

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: